U.S.-listed shares of cannabis firms jump premarket
Washington Post reports U.S. President Donald Trump is expected to push the government to dramatically loosen federal restrictions on marijuana, citing people familiar with the discussions
Report says Trump discussed plan with House Speaker Mike Johnson on Wednesday
Trump said in August his administration is considering reclassifying marijuana; currently its listed as Schedule I substance
Move expected to re-classify it as Schedule III substance, report says
Canopy Growth (CGC.O) surges 18.1%, Cronos Group (CRON.O) jumps 11.9%, Tilray Brands (TLRY.O) climbs 28.4%
SNDL (SNDL.O) and Aurora Cannabis (ACB.O) gain 11.3% and 15%, respectively
AdvisorShares Pure US Cannabis ETF (MSOS.P) jumps 31.7%, and Roundhill Cannabis ETF (WEED.P) gains 27.8% in low vols

TLRY

CRON

U.S.-listed cannabis stocks surged after reports that President Trump may ease federal marijuana restrictions, potentially reclassifying it from Schedule I to Schedule III. Canopy Growth, Cronos Group, Tilray Brands, SNDL, and Aurora Cannabis saw significant gains, along with cannabis ETFs AdvisorShares Pure US Cannabis and Roundhill Cannabis.

- U.S.-listed shares of cannabis firms surged in premarket trading following reports that President Donald Trump plans to ease federal restrictions on marijuana.  
- Trump discussed the potential reclassification of marijuana from a Schedule I to a Schedule III substance with House Speaker Mike Johnson, which could significantly impact the cannabis industry.  
- Notable stock increases included Canopy Growth rising 18.1%, Cronos Group up 11.9%, and Tilray Brands climbing 28.4%, alongside substantial gains in cannabis ETFs.

BUZZ-Pot stocks climb on report Trump considers easing marijuana restrictions